More about

Vertebral Fracture

News
June 24, 2022
2 min read
Save

Romosozumab improves BMD, reduces fracture risk in women with osteoporosis and CKD

Romosozumab improved bone mineral density at the lumbar spine, total hip and femoral neck, and reduced the relative risk for fractures in women with osteoporosis and mild-to-moderate chronic kidney disease, according to study data.

News
May 02, 2022
2 min read
Save

Vertebral fracture risk increased for adults with acromegaly, high growth hormone levels

Adults with acromegaly are more likely to experience a vertebral fracture than those without the disease, and high growth hormone levels increase fracture risk, according to study data from Italy.

News
October 29, 2021
2 min read
Save

‘Consistent reductions’ in moderate, severe vertebral fractures with romosozumab therapy

Romosozumab is associated with marked reductions in all vertebral fracture grades, and these are sustained after transition to antiresorptive agents, post hoc analyses from the FRAME and ARCH studies show.

News
October 24, 2021
1 min read
Save

Amber Implants receives FDA breakthrough device designation for spinal system

Amber Implants has announced FDA breakthrough device designation for the VCFix spinal system for treatment of vertebral fractures, according to a company press release.

News
July 27, 2021
2 min read
Save

Even low-dose glucocorticoids greatly increase vertebral fracture risk in RA

Patients with rheumatoid arthritis who receive even low daily doses of glucocorticoids are at a 59% increased risk for clinical vertebral fracture, according to data published in Rheumatology.

News
October 22, 2020
3 min read
Save

Vertebral fractures ‘objective clinical marker’ of frailty, prognosis in COVID-19

Morphometric vertebral fractures are one of the most common comorbidities among adults hospitalized with COVID-19, and the presence of such fractures may predict the severity of disease outcomes, study data show.

News
July 29, 2020
2 min read
Save

Delayed denosumab injections raise vertebral fracture risks

Delaying denosumab doses by more than 4 months is associated with increased risks for vertebral fracture compared with on-time injections, according to findings published in Annals of Internal Medicine.

News
June 10, 2020
2 min read
Save

Romosozumab reduces vertebral fracture risk in postmenopausal osteoporosis

Women with postmenopausal osteoporosis who received the monoclonal antibody romosozumab were less likely to sustain a vertebral fracture during 12 months of treatment compared with women who received placebo or alendronate, study data show.

News
May 20, 2020
2 min read
Save

Thyroid-stimulating antibody positivity may predict vertebral fracture risk in Graves’ disease

A cohort of postmenopausal Japanese women were more likely to sustain a vertebral fracture if they had thyroid-stimulating antibodies compared with women without the antibody, independent of age and severe osteoporosis status, according to findings published in Clinical Endocrinology.

News
January 20, 2020
2 min read
Save

Pheochromocytoma, paraganglioma underrecognized cause of secondary osteoporosis

Adults with pheochromocytoma or paraganglioma are nearly five times more likely to experience a vertebral fracture, a hallmark of osteoporosis, when compared with adults with nonfunctional adrenal tumors, according to findings published in Bone.

View more